Page last updated: 2024-09-04

tei 5103 and dinoprostone

tei 5103 has been researched along with dinoprostone in 1 studies

Compound Research Comparison

Studies
(tei 5103)
Trials
(tei 5103)
Recent Studies (post-2010)
(tei 5103)
Studies
(dinoprostone)
Trials
(dinoprostone)
Recent Studies (post-2010) (dinoprostone)
130429,1051,3466,357

Protein Interaction Comparison

ProteinTaxonomytei 5103 (IC50)dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtypeHomo sapiens (human)0.0155
Prostaglandin E2 receptor EP4 subtypeHomo sapiens (human)0.0031
Prostaglandin E2 receptor EP4 subtypeRattus norvegicus (Norway rat)0.0021
Prostaglandin E2 receptor EP3 subtypeHomo sapiens (human)0.002
Prostaglandin E2 receptor EP2 subtypeHomo sapiens (human)0.0087
Prostacyclin receptorHomo sapiens (human)0.26
Prostaglandin E2 receptor EP2 subtypeRattus norvegicus (Norway rat)0.0052

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoshina, K; Naruchi, T; Suwa, Y; Takahama, S; Takeshita, T; Yamazaki, N1

Other Studies

1 other study(ies) available for tei 5103 and dinoprostone

ArticleYear
Effect of a new anti-ulcer drug, (3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride, TEI-5103) on prostaglandin (PG) levels in rat gastric mucosa.
    General pharmacology, 1988, Volume: 19, Issue:4

    Topics: Animals; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Dinoprostone; Gastric Mucosa; Hydroxyprostaglandin Dehydrogenases; Male; Phenylpropionates; Phospholipases A; Phospholipases A2; Prostaglandins; Prostaglandins E; Radioimmunoassay; Rats; Rats, Inbred Strains

1988